The Informed Woman Magazine - Healthcare Science for Women

- Polycystic Ovary Syndrome

PCOS Isn’t One-Size-Fits-All: New Research Identifies Four Distinct Subtypes — And What That Means for You

Polycystic ovary syndrome (PCOS) affects an estimated 11 to 13% of women worldwide and is one of the most common endocrine disorders in reproductive-age women. Yet despite its prevalence, PCOS has long been treated as a single diagnosis, even though women experience it in strikingly different ways. Some struggle primarily with irregular cycles and infertility, others with weight gain, insulin resistance, or long-term cardiometabolic disease.

- Editorial
- Free Articles

Society Has Evolved Biology Hasn’t

Across the Western world, the age at which women become mothers has steadily increased over the past several decades, reflecting profound social, economic, and cultural shifts. In the mid-20th century, first births commonly occurred in a woman’s early to mid-20s, closely tied to earlier marriage and more traditional life trajectories. Today, however, the average age at first birth in most Western countries has moved into the late 20s or early 30s, with a growing proportion of women having their first child at 35 years or older.

- Fertility

AI Ultrasound Analysis is More Accurate Than Cervical Length in Predicting Preterm Birth

Preterm birth, defined as delivery before 37 completed weeks of pregnancy, affects roughly one in ten pregnancies worldwide and remains the leading cause of neonatal mortality. Beyond the immediate risks to newborn survival, babies born too early face higher rates of long-term health challenges, including respiratory disease, neurodevelopmental delays, and chronic conditions that can persist into adulthood.

- Fertility
- Free Articles

A Brave New World – Advances in Reproductive Technology

Advances in reproductive medicine are opening doors that were unimaginable just a generation ago, particularly for women concerned about inherited disease and fertility loss. Emerging technologies such as mitochondrial replacement therapy, gene editing, and the development of artificial gametes promise new ways to prevent severe genetic disorders and expand reproductive options. For women who carry known genetic mutations or who have lost fertility due to age, cancer treatment, or medical conditions, these innovations offer the possibility of having healthy, genetically related children; an outcome that until recently was often out of reach.

- Fertility

Mitochondrial Diseases a Maternal Legacy

Mitochondria are inherited almost exclusively from the mother through the egg cell. During fertilization, the sperm contributes mainly its nuclear DNA, while its mitochondria, located in the sperm’s tail, either fail to enter the egg or are actively destroyed after entry. As a result, all the mitochondria in an embryo come from the mother’s egg, making mitochondrial DNA (mtDNA) maternally inherited.

- Polycystic Ovary Syndrome

PCOS Explained (Part 1) – The Hidden Hormone Loop

Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder characterized by an interplay between genetic, metabolic, and hormonal abnormalities that lead to ovarian dysfunction, hyperandrogenism, and metabolic disturbances. The pathophysiology begins with insulin resistance, which occurs in many but not all women with PCOS and contributes significantly to its endocrine and metabolic features.

- Polycystic Ovary Syndrome

PCOS Treatment (part 2) How to Break the Cycle

The treatment of polycystic ovary syndrome (PCOS) is multifaceted because the condition involves hormonal imbalance, metabolic dysfunction, and reproductive irregularities. Management typically begins with lifestyle modification, as even a modest 5–10% weight reduction can significantly improve ovulation, insulin sensitivity, and androgen levels.

- Polycystic Ovary Syndrome

Why Are You Afflicted With PCOS? (Part 3) The Epigenetic Layer

Epigenetic mechanisms appear to play a significant role in the pathophysiology of polycystic ovary syndrome (PCOS), helping explain how genetic susceptibility interacts with environmental and developmental factors to produce the syndrome’s diverse reproductive and metabolic manifestations.

- Free Articles
- Neurogenerative Disorders

Why Women Are More Susceptible to Neurodegeneration & A Commonly Used Drug, Metformin May Be Protective

Multiple sclerosis and Alzheimer’s disease each affect women more often than men, about two to three times as often. Also, two-thirds of healthy women have ‘brain fog’ during menopause. Hormones such as estrogen clearly play a role, but their decline does not fully account for why female brains appear more vulnerable to neuroinflammatory and neurodegenerative processes.

- Endometriosis

New Treatment Strategies for Endometriosis and Adenomyosis

Oral GnRH antagonists have become an important advancement in the medical management of endometriosis and are increasingly being explored for adenomyosis. These agents work by directly blocking GnRH receptors in the pituitary gland, producing an immediate decrease in LH and FSH and therefore suppressing ovarian estrogen production without causing the “flare effect” seen with older GnRH agonists.